Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preventing School Exclusion and Opioid Misuse: Effectiveness of the Inclusive Skill-building Learning Approach (ISLA)

NCT06292078 is registered in ClinicalTrials.gov with University of Oregon as lead sponsor.

NCT NCT06292078
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06292078 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preventing School Exclusion and Opioid Misuse: Effectiveness of the Inclusive Skill-building Learning Approach (ISLA)
Lead sponsor
University of Oregon
Phase
Not applicable
Overall status
Recruiting
Start date
April 15, 2024
Completion date
October 1, 2027
Enrollment
5,076 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

middle schools, opioid and other substance misuse, school community, school exclusion, teaching practices